Study design and endpoints in graft-versus-host disease

Best Practice and Research: Clinical Haematology

Volumn 21, Issue 2, 2008, Pages 357-372

  Martin, Paul J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

clinical trials; design; graft versus host disease

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; IMMUNOTOXIN;

ACUTE GRAFT VERSUS HOST DISEASE; CANCER RISK; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENTIALITY; CONSENSUS DEVELOPMENT; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; FOLLOW UP; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTHESIS; IMMUNOREGULATION; INFECTION RISK; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; METHODOLOGY; MORTALITY; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PATIENT CARE PLANNING; PATIENT INFORMATION; PATIENT SAFETY; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE STUDY; RELAPSE; RELIABILITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STANDARDIZATION; SURVIVAL RATE; SURVIVAL TIME;

CLINICAL TRIALS AS TOPIC; GRAFT VS HOST DISEASE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN;

EID: 44049095479     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2008.03.001     Document Type: Review

References (23)

1. Martin P.J., Weisdorf D.W., Przepiorka D., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group Report. Biology of Blood and Marrow Transplantation 12 (2006) 491-505
2. 21 CFR 314.126(b).
3. Schultz K.R., Miklos D.B., Fowler D., et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biology of Blood and Marrow Transplantation 12 (2006) 126-137
4. Wittes R.E. Antineoplastic agents and FDA regulations: square pegs for round holes?. Cancer Treatment Reports 71 (1987) 795-806
5. Anonymous. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. Journal of Clinical Oncology 14 (1996) 671-679
6. Gooley T.A., Rajvanshi P., Schoch H.G., et al. Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation. Hepatology 41 (2005) 345-352
7. Martin P.J., Schoch G., Gooley T., et al. Methods for assessment of graft-versus-host disease (letter). Blood 92 (1998) 3479-3481
8. Strasser S.I., and McDonald G.B. Gastrointestinal complications. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' Hematopoietic Cell Transplantation. 3rd ed. (2004), Blackwell, Malden MA 769-810
9. Filipovich A.H., Weisdorf D., Pavletic, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report. Biology of Blood and Marrow Transplantation 11 (2005) 945-955
10. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report. Biology of Blood and Marrow Transplantation 12 (2006) 31-47
11. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation 12 (2006) 252-266
12. Couriel D., Carpenter P., Cutler C., et al. Ancillary Therapy and Supportive Care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation 12 (2006) 375-396
13. Martin P.J., Nelson B.J., Appelbaum F.R., et al. Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 88 (1996) 824-830
14. Przepiorka D., Weisdorf D., Martin P., et al. 1994 consensus conference of acute GVHD grading. Bone Marrow Transplantation 15 (1995) S98-S103
15. Martin P.J., Pei J., Gooley T., et al. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Biology of Blood and Marrow Transplantation 10 (2004) 552-560
16. Fefer A. Graft-versus-tumor responses. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' Hematopoietic Cell Transplantation. 3rd ed. (2004), Blackwell, Malden MA 369-379
17. Sandmaier B.M., and Storb R. Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' Hematopoietic Cell Transplantation. 3rd ed. (2004), Blackwell, Malden MA 1164-1176
18. Marmont A.M., Horowitz M.M., Gale R.P., et al. T-cell depletion of HLA-identical transplantation in leukemia. Blood 78 (1991) 2120-2130
19. Bacigalupo A., Van Lint M.T., Occhini D., et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood 77 (1991) 1423-1428
20. Ferrara J.L., and Reddy P. Pathophysiology of graft-versus-host disease. Seminars in Hematology 43 (2006) 3-10
21. Shlomchik W.D. Graft-versus-host disease. Nature Reviews. Immunology 7 (2007) 340-352
22. Welniak L.A., Blazar B.R., and Murphy W.J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annual Review of Immunology 25 (2007) 139-170
23. Chu Y.W., and Gress R.E. Murine models of chronic graft-versus-host disease: insights and unresolved issues. Biology of Blood and Marrow Transplantation 14 (2008) 365-378